Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV003470059 | SCV004194269 | likely pathogenic | 3-methylcrotonyl-CoA carboxylase 1 deficiency | 2023-08-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003470059 | SCV004629320 | pathogenic | 3-methylcrotonyl-CoA carboxylase 1 deficiency | 2023-01-06 | criteria provided, single submitter | clinical testing | This premature translational stop signal has been observed in individual(s) with clinical features of 3-methylcrotonyl-CoA carboxylase deficiency (PMID: 31901042). This sequence change creates a premature translational stop signal (p.Arg544Aspfs*2) in the MCCC1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MCCC1 are known to be pathogenic (PMID: 11181649, 15359379, 22642865). This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. |